Startups

Manager, CMC Project Management

Aura Biosciences · Brighton, Massachusetts · On-site

← All jobs
About Aura Biosciences

Aura Biosciences is pioneering a first-in-class technology to treat a wide variety of solid tumor types. We are initially pursuing cancers where patients are in need of a transformational change in treatment options, such as choroidal melanoma, so they can... Backed by Foresite Capital.

About the role

Reporting to Associate Director, CMC Program Management, the CMC Project Manager will be responsible for managing CMC drug development activities working cross-functionally within internal Technical Operations, Quality, Regulatory, Device and Clinical Teams and externally with numerous CDMOs. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Bachelor’s degree in pharmaceutical sciences, biotechnology, engineering, life sciences or a related field (or equivalent working experience), PMP or equivalent certification preferred but not required
  • Minimum of 5 years of experience in Pharmaceutical or Biotechnology related field including at least 3 years of project management experience, with direct CMC, drug development and cross-functional experience
  • Strong knowledge and application of standard Project Management tools with experience in Smartsheet, MS Project, Power Point, Excel and SharePoint
  • Direct CMC experience with solid understanding of drug development lifecycle from pre-clinical to commercial
  • Experience working with CDMOs (e.g., tech transfer, batch execution, process or analytical validation) preferred
  • Ability to clearly and concisely disseminate and manage information flow across all levels of the organization
More about this role

About Aura Biosciences

Aura Biosciences is a clinical-stage biotechnology company developing bel-sar, a potentially transformative, first-in-class therapy for patients living with ocular cancers. Bel-sar represents an entirely novel approach to treating ocular cancers via its dual mechanisms of action of acute tumor necrosis and secondary anti-tumor immune activation. The Phase 3 registration study of Bel-sar in early choroidal melanoma, the largest patient segment of uveal melanoma, is fully enrolled, and earlier stage studies in metastases to the choroid and cancers of the ocular surface are ongoing. Aura's mission is to improve outcomes for patients living with ocular cancers by delivering a therapy that not only arrests tumor growth but also preserves vision and quality of life.

For more information, visit aurabiosciences.com . Follow us on X, @AuraBiosciences, and visit us on LinkedIn.

Reporting to Associate Director, CMC Program Management, the CMC Project Manager will be responsible for managing CMC drug development activities working cross-functionally within internal Technical Operations, Quality, Regulatory, Device and Clinical Teams and externally with numerous CDMOs....

Read the full posting on Aura Biosciences's site ↗

CMC

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.